
NASDAQHealthcareBiotechnology
最新数据
US$2.80
−US$0.13 · -4.44%
Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services. These include aiding in business and market expansion, formulating strategic growth plans, identifying and acquiring talent, fostering key partnerships, facilitating capital raising efforts, and orchestrating company acquisitions or sales. The organization, which was established in 1993 and is headquartered in Beverly Hills, California, rebranded as Nordicus Partners Corporation in May 2023, having previously been known as EKIMAS Corporation.
前收盘价
US$2.80
−US$0.13 · -4.44%
盘中时间采用ET。市场数据可能有所延迟。
Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services. These include aiding in business and market expansion, formulating strategic growth plans, identifying and acquiring talent, fostering key partnerships, facilitating capital raising efforts, and orchestrating company acquisitions or sales. The organization, which was established in 1993 and is headquartered in Beverly Hills, California, rebranded as Nordicus Partners Corporation in May 2023, having previously been known as EKIMAS Corporation.
日内区间
当前US$2.80
52周区间
当前US$2.80
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | — | 5000 USD | 2500 USD | — | — |
| 销货成本 | 5198 USD | — | — | — | — |
| 毛利 | −5198 USD | — | — | — | — |
| 研究与开发 | 160.7万 USD | 132.94万 USD | — | — | — |
| 销售、一般及管理费用 | 183.08万 USD | 68.35万 USD | 19.16万 USD | 2.99亿 USD | 30.92万 USD |
| 营业费用 | 437.1万 USD | 292.44万 USD | 31.01万 USD | 84.8亿 USD | 30.9万 USD |
| 利息支出 | −642 USD | 200 USD | — | −38.2万 USD | — |
| 折旧和摊销 | 5198 USD | 5174 USD | — | — | 23.66万 USD |
| 营业利润 | −437.1万 USD | −291.94万 USD | −30.76万 USD | −84.73亿 USD | −30.9万 USD |
| 净利润 | −400.17万 USD | −290.13万 USD | −29.82万 USD | −84.65亿 USD | −26.5万 USD |
公司数据更新于 2026年11月22日。
近期已公布业绩
近期已公布业绩
年度分割调整后的每股现金分配。
US$12.50
2022年(完整年度)+38.9% 自从 2020
US$9.00
2,020
US$12.50
2,022
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2022年3月10日 | US$0.25Special | — | — |
股息 | 2020年4月24日 | US$0.18Special | — | — |
除息 2022年3月10日
US$0.25
Special
除息 2020年4月24日
US$0.18
Special
AI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。